Skip to main content
. 2021 Nov 25;72(4):695–707. doi: 10.1007/s12031-021-01930-7

Table 4.

Oxytocin levels in plasma and urine: Means (M) and standard deviations (SD)

Patients only
Healthy controls Patients No remission Remission
M SD n M SD n M SD n M SD n
Plasma oxytocin T1 before interview 327.05 136.24 41 322.77 122.43 43 319.92 117.22 26 328.06 137.90 16
Plasma oxytocin T1 after interview 345.59 196.14 41 340.26 123.66 43 321.96 113.99 26 367.13 140.26 16
Plasma oxytocin T2 before interview 351.49 127.96 41 354.05 117.29 41 339.24 118.34 25 377.19 115.52 16
Plasma oxytocin T2 after interview 346.00 148.92 41 335.44 115.66 41 320.08 113.47 25 359.44 118.58 16
Oxytocin in urine T1 204.00 127.19 41 156.50 134.58 40 140.46 102.85 24 184.60 178.04 15
Oxytocin in urine T2 228.26 166.48 42 158.59 128.73 41 155.68 147.72 25 163.12 96.15 16

N = 84

Oxytocin plasma levels were taken twice at each visit — first sample before and second sample after a biographical interview. Data of patients is given twice, column 2 shows data of all MDD patients, columns 3 and 4 show the data according to the final outcome of the patients. Remission was defined based on the HAM-D score at the second visit (< 8). Differences in n’s are due to missing data. All oxytocin levels are given as [pg/ml]. Further details are summarized in the “Results” section